LumiThera
Scott Bradley is the Senior Director of Product Development at LumiThera. Prior to LumiThera, Mr. Bradley was the Senior Director of Product Development at Vital Therapies, Director of Product Development at PhotoThera, and a program management consultant to medical device and in-vitro diagnostic companies. Mr. Bradley has 24 years of experience including engineering design and program management for research, clinical trial, and commercial device development. Therapeutic areas include ophthalmology, oncology, hepatology, neurology and dentistry. Mr. Bradley earned a Bachelor of Science, Mechanical Engineering from Colorado State University and is the coauthor of 10 issued patents.
This person is not in any teams
This person is not in any offices
LumiThera
1 followers
At LumiThera, they are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. They will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company’s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area.